Precipio Inc.

About Precipio Inc.

Precipio is a specialty cancer diagnostics company focused on delivering advanced hematopathology diagnostic products and services. Their mission is to achieve superior diagnostic accuracy for blood cancer patients and physicians through cutting-edge technology, specialized expertise, and efficient testing processes. They commercialize technologies from their clinical laboratory into products sold via global distribution partners.

Products & Services

Molecular Kits:Designed to detect driver mutations related to MPN, CML, CLL, AML, and MDS blood cancers.

Bloodhound BCR-ABL1 Panel:A molecular panel for detecting BCR-ABL1 mutations in blood cancers.

Bloodhound MPN Panel:A panel for detecting mutations related to myeloproliferative neoplasms (MPN).

HemeScreen AML Panel:A molecular kit for detecting mutations in acute myeloid leukemia (AML).

IV-Cell Cytogenetics Culture Media:Multi-cell lineage culturing media with simplified workflow and high clinical accuracy.

Hematopathology Clinical Services:Diagnostic services for blood cancer testing with high accuracy, quality, and service standards.

Specialties

Hematopathology Blood Cancer Diagnostics Molecular Assays Proprietary Diagnostic Technologies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 1200000 MR: - FA: ~$1.2M FAN: 1200000	D: 2025-07-11 FD: 2025-07-11	-
2	RT: Debt T: - FT: Debt	A: 500000 MR: - FA: 500K FAN: 500000	D: 2024-05-06 FD: 2024-05-06	-
3	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 2000000 MR: - FA: 2 million FAN: 2000000	D: 2023-06-08 FD: 2023-06-08	1 investors

Warrant Exercise Latest

2025-07-11

$1.2M

Debt 2024-05-06

$500K

Registered Direct Offering and Private Placement 2023-06-08

$2.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Frank Bauer

Medical Director

J

Jason Willis

board-certified hematopathologist

H

Hina Naushad Qureishi

Hematopathologist

B

Bevan Tandon

Board Certified Hematopathologist

S

Seble Chekol

board certified hematopathologist

L

Laura Wake

Hematopathologist

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Precipio Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised